Nutriband Inc
NASDAQ:NTRB 4:00:00 PM EDT
| Market Cap (Intraday) | 87.78M |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | 5.01 |
| 10-Day MA | $7.78 |
| 50-Day MA | $6.61 |
| 200-Day MA | $6.01 |
Nutriband Inc Stock, NASDAQ:NTRB
121 South Orange Avenue, Suite 1500, Orlando, Florida 32801
United States of America
Phone: +1.407.377.6695
Number of Employees:
Description
Nutriband, Inc. engages in the development of a portfolio of transdermal pharmaceutical products. It operates through the Pocono Pharmaceuticals and 4P Therapeutics segments. The Pocono Pharmaceuticals segment relates to a coated products manufacturing entity. The 4P Therapeutics segment performs contract research and development services. The company was founded by Gareth R. Sheridan and Serguei Melnik in 2012 and is headquartered in Orlando, FL.